Research & Development: Page 38
-
PharmaVoice Team/PharmaVoice
Healthcare Needs A Hero
Hero is a big word. The image it brings to mind is someone who saves the day or who stands up for what is right. The bar is set pretty high for what makes a hero today. The pharma industry is full of heroes. They don’t walk around wearing capes or rappel down the face of a skyscraper to take out ...
By Patrick Lindsay • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Complexity and Specialization: An Inevitable Dance
For decades, general practitioners successfully managed the healthcare needs of entire families. From treating the common cold to addressing urgent injuries, from delivering babies to providing geriatric care, the family doctor was there to see us through all walks and phases of life. Today, alth...
By Donal A. Deieso • June 1, 2016 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Transforming Diabetes Treatment Paul Laikind, Ph.D., President and CEO of ViaCyte, talks about the company’s research on a stem-cell derived therapy for diabetes. About 29.1 million people — about 1 out of every 11 people — have diabetes. About 5%, or about 1.25 million people, have type 1 diabet...
By Paul Laikind • May 1, 2016 -
PharmaVoice Team/PharmaVoice
HIV Vaccine Update
In 2015, Bill Gates caused a media stir by expressing optimism that a vaccine and a cure for HIV will become a reality within the next 15 years. The National Institutes of Health and other researchers have made progress in understanding how HIV antibodies develop and the potential of a vaccine to...
By Denise Myshko • May 1, 2016 -
PharmaVoice Team/PharmaVoice
HBA Rising Stars: Healthcare Vision 2020
PharmaVOICE has exclusive access to nearly 100 women leaders, who are providing their take on the trends that are expected to shape the healthcare industry in the next four years. Identified by their companies as HBA Rising Stars and Luminaries, these industry executives talk about everything fro...
By PharmaVoice Team • May 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
TransCelerate BioPharma Introduces New Subsidiary Trending now: Six biopharmaceutical companies launch subsidiary with first initiative-toxicology data sharing. TransCelerate BioPharma has launched BioCelerate, a new subsidiary that aims to improve efficiencies in preclinical research. The six in...
By PharmaVoice Team • April 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Physicians Value Digital Sales Aids Trending now: Survey of physicians reveals they want stronger and more custom content from sales aids. While most pharmaceutical representatives today are armed with tablet devices and direct sales aids (DSAs), many are not using them effectively during physici...
By PharmaVoice Team • April 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions DIA 2016 — a Gathering of Global Proportions — is the largest global interdisciplinary event that brings together 7,000-plus key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations in Phila...
By PharmaVoice Team • April 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovative Science and Products
Innovation in the life-sciences industry is widely diverse. Products range from Google’s Lift Lab’s “super spoon" to help people with essential tremors and Parkinson’s disease to eat without spilling — in clinical trials, the Liftware spoons reduced shaking of the spoon bowl by an average of 76% ...
By PharmaVoice Team • April 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Targeted Cancer Treatment Dr. Joshua Allen, VP for Research and Development at Oncoceutics, talks about his company’s approach to target cancer. Targeted therapies are the focus of many cancer drug development programs. They are a cornerstone of precision medicine, which uses information a...
By Dr Joshua Allen • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Protocol Amendments Come at a High Cost Trending now: New analysis provides insight into the impact of clinical trial amendments and how to anticipate and manage them. Research sponsors implement at least one substantial global amendment for almost 60% of all clinical trial protocols, substantia...
By PharmaVoice Team • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Preparing for an Outcomes-based Sales Model
According to a recent report by Accenture, three factors — reimbursement models, changing buyer profiles, and digital capabilities — are changing the pharmaceutical and healthcare industries and directly impacting the traditional pharmaceutical sales rep model. However, these factors also represe...
By Robin Robinson • March 1, 2016 -
PharmaVoice Team/PharmaVoice
The Microbiome: A New Research Tool
Our bodies are home to trillions of microbes, including bacteria, fungi, and viruses. These microbes are essential; they help digest food, produce certain vitamins, and regulate the immune system. Until recently, little was known about these microbes, but advances in DNA sequencing are making it ...
By Denise Myshko • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Biopharma Sales Operations Stabilizing Trending now: Growth in sales operations spending driven by changing biopharma challenges and priorities. The biopharmaceutical sales operations rollercoaster ride appears to have leveled off, according to TGaS Advisors. A recent TGaS Commercial Operations L...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Pennsylvania BIO 2016 Annual Dinner and Awards Celebration is the premier event of the season for the life-sciences industry in Pennsylvania. On March 10th, more than 1,000 attendees will convene for this can’t-miss event Thursday, March 10, 2016, at the PA Convention Cente...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Strategic Partnerships
After years of paying lip service to the need for truly strategic partnerships between sponsors and CROs as a way to increase efficiencies, improve timelines to market, and reduce costs, the time may be right for both parties. According to Nice Insights’ most recent survey 2016 CRO Buying Trends,...
By Taren Grom • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Countdown to Launch: Strategies For Efficiency, Acceleration and Performance
As new drug launches proliferate in the increasingly complex specialty therapeutic space, biopharma is finding that success is often pre-determined by actions that take place very early in the development and commercialization cycle. In fact, the earlier companies start thinking through their lau...
By Dean Giovanniello • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Helping Kids with Asthma Medikidz and Meda Pharmaceuticals have launched Explain Asthma, a comic book series launched in conjunction with the American College of Asthma, Allergy, and Immunology (ACAAI). The series is designed to help families gain an accurate understanding of as...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Modifying the Immune System for Those with Food Allergies DBV Technologies’ CEO and Co-founder Pierre-Henri Benhamou talks about his company’s development of a patch for peanut and other food allergies. The prevalence of food allergies appears to be on the rise. While there is no cure for food al...
By Pierre-Henri Benhamou • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Filling Unmet Needs for Patients David Meek, Executive VP and President, Oncology, Baxalta, talks about how pharmaceutical companies can bridge the research gap in areas of high unmet need. PV: What do you think is needed to translate scientific advances into real benefits for patients? Meek: Col...
By David Meek • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Brain: The Decade Ahead
The three-pound organ — made up of more than 100 billion nerves — that serves as the center of the nervous system is one of the most complex parts of the human body. Only recently have researchers and scientists begun to understand the brain and what can go wrong. This special forum kicks off a y...
By Denise Myshko and Robin Robinson • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
CROs’ Use of eTMF Apps Increases: Veeva Survey Trending Now: A majority of CROs cite speeding study start-up as top driver for eTMF technology adoption. A significant number of contract research organizations (CROs) are increasingly using electronic trial master file (eTMF) applications, accor...
By PharmaVoice Team • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
TGaS Insights Launches Report Service for Pharmaceutical Commercial Leaders Trending Now: New service provides an “outside-in" perspective on what’s happening beyond the four walls of life-sciences companies. TGaS Insights, a division of TGaS Advisors, has launched TGaS Insights Reports, a new ...
By PharmaVoice Team • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
2016 The Year Ahead
For this special issue — the Year in Preview: 2016 — we identified 10 major trends that are expected to continue to disrupt the industry in new and different ways. There were a multitude of industry drivers from a multitude of industry sources to consider. We identified these 10 trends — that spa...
By Taren Grom • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
The Brain in the Decade Ahead
In 2013, President Obama launched the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN Initiative, as a large-scale effort to equip researchers with fundamental insights necessary for treating a wide variety of brain disorders such as Alzheimer’s, schizophrenia, autism, epi...
By Taren Grom • Nov. 15, 2015
Previous
